| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 5e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |